[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,913
Citations 0
Case Report/Case Series
December 2015

Brugada Syndrome Presenting as Polymorphic Ventricular Tachycardia–Ventricular Fibrillation Lasting 94 Seconds Recorded on an Ambulatory Monitor

Author Affiliations
  • 1Section of Cardiology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
JAMA Intern Med. 2015;175(12):1951-1954. doi:10.1001/jamainternmed.2015.5934

Importance  Cardiac arrhythmias are common causes of syncope. Brugada syndrome is an uncommon but serious genetic arrhythmia disorder that can be unmasked by medicines causing sodium channel blockade.

Observations  This report documents a case of Brugada syndrome and polymorphic ventricular tachycardia–ventricular fibrillation not initially recognized in a patient taking nortriptyline and experiencing syncope. It also illustrates one of the longest episodes of ventricular fibrillation recorded on an ambulatory monitor (94 seconds). Although the baseline electrocardiogram did not demonstrate a typical appearance for Brugada syndrome, provocative testing with flecainide in this patient with documented polymorphic ventricular tachycardia revealed a Brugada electrocardiogram pattern.

Conclusions and Relevance  Vigilance should be maintained for arrhythmia substrates such as Brugada syndrome in patients with typical symptoms when they are prescribed membrane-active medicines. Long-term ambulatory rhythm monitors can provide useful information in these cases, especially when symptoms are infrequent.